About Us
Fund
Support
Return
About Us
Fund
Support
Return
Our DNA
News
Join Our Team
Contact
Investor Portal
NEWS
Our Latest News
ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist
View All
2022
2021
2020
2019
2018
2017
2016
2015
2014
ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist
October
7,
2022
ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge
October
4,
2022
ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal
July
21,
2022
ARCHIMED invests in Title21 Health Solutions, a leading US-based healthcare software provider
July
12,
2022
ARCHIMED invests in Corealis Pharma, a North American CDMO, through MED III
May
24,
2022
ARCHIMED’s MED II fund earns a 6x return on its first exit
May
9,
2022
1
2
3
…
12
>
